课题基金 / 基金详情

DNA damage responses in mammalian cells and their contribution to human health disorders; the end-stage.

DNA damage responses in mammalian cells and their contribution to human health disorders; the end-stage.
哺乳动物细胞中的 DNA 损伤反应及其对人类健康疾病的影响;
批准号:
G1000050/1
负责人:
Penny Jeggo
金额:
$55.63万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2011
资助国家:
英国
项目状态:
已结题
起止时间:
2011 至 --

项目摘要

项目成果

Penny Jeggo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
All cells in our body carry the same genetic information encoded within the DNA sequence. The entire DNA sequence represents our genome. Our DNA is constantly damaged by exogenous and endogenously arising reactive chemicals. It is important that our genomes are stably maintained without any sequence changes. The maintenance of genomic stability is crucial for cancer avoidance and for normal growth and development. Genomic stability is maintained by DNA damage response mechanisms. Individuals impaired in such mechanisms have been described and can display elevated cancer predisposition, abnormal development and/or enhanced sensitivity to environmental agents such as ionizing radiation (IR). My laboratory studies the response to DNA double strand breaks (DSBs), which arise when both strands of the DNA molecule are broken in close proximity. DSBs are commonly induced by exposure to IR. The major process that repairs DSBs is called DNA non-homologous end-joining (NHEJ). The MRC has funded my laboratory for more than ten years to study the response to DSBs. The aim of this proposal is to complete the ongoing programme of work prior to my retirement. In one component of work, we have shown that the organization of DNA influences how it is repaired. DNA regions that are rarely used are more highly compacted than those that encode proteins that are required frequently. The most highly compacted DNA, called heterochromatin, is repaired more slowly than more open DNA and the repair requires additional proteins. We will seek insight into this process. The development of the immune response requires the creation of a diverse repertoire of cells that recognize different antigens. This is achieved by the creation of DSBs which are rejoined inaccurately. Curiously cells utilize NHEJ to create diversity during immune development and to maintain stability after accidental DSB formation. Patients defective in NHEJ proteins have been described and show immunodeficiency as well as IR sensitivity. They also frequently have small heads at birth demonstrating that NHEJ is required for normal neuronal development. We have characterised a mouse model for one such disorder called LIG4 Syndrome. We will complete the analysis of LIG4 mice to gain insight into the basis underlying the small head phenotype of LIG4 patients. Finally, we have also examined the basis underlying Seckel Syndrome, another disorder conferring small heads and developmental delay. We have identified genetic defects for Seckel Syndrome and will complete our current studies on the identified proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the BAF180 remodelling complex in transcriptional repression and DNA double strand break repair in mammalian cells.
  • 批准号:
    MR/K001604/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $43.7万
  • 财政年份:
    2012
  • 负责人:
    Penny Jeggo
  • 依托单位:
The basis underlying microcephaly caused by defects in replication or DNA repair.
  • 批准号:
    MR/J001007/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $48.44万
  • 财政年份:
    2012
  • 负责人:
    Penny Jeggo
  • 依托单位:
DNA damage responses in mammalian cells and their contribution to human health disorders
  • 批准号:
    G0500897/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $189.97万
  • 财政年份:
    2006
  • 负责人:
    Penny Jeggo
  • 依托单位:
国内基金
海外基金
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
  • 批准号:
    82372167
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    江继宏
  • 依托单位:
槲皮素控释系统调控Mettl3/Per1修复氧化应激损伤促牙周炎骨再生及机制研究
  • 批准号:
    82370921
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    徐袁瑾
  • 依托单位:
解码精母细胞特异5’UTR元件调控DNA损伤修复基因MSH5翻译挽救减数分裂障碍的研究
  • 批准号:
    82371607
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    李铮
  • 依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究